tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BioArctic CEO Gunilla Osswald Honored as Uppsala University’s Alumnus of the Year 2025
Company AnnouncementsBioArctic CEO Gunilla Osswald Honored as Uppsala University’s Alumnus of the Year 2025
2d ago
BioArctic Founders to Divest Minor Shareholdings
PremiumCompany Announcements
BioArctic Founders to Divest Minor Shareholdings
8d ago
BioArctic and Eisai Advance Alzheimer’s Treatment with FDA Submission
PremiumCompany Announcements
BioArctic and Eisai Advance Alzheimer’s Treatment with FDA Submission
9d ago
FDA Approves BioArctic’s Subcutaneous Alzheimer’s Treatment
PremiumCompany Announcements
FDA Approves BioArctic’s Subcutaneous Alzheimer’s Treatment
13d ago
BioArctic AB Sees Growth with Leqembi® and Novartis Partnership
PremiumCompany Announcements
BioArctic AB Sees Growth with Leqembi® and Novartis Partnership
14d ago
B9A Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsB9A Earnings Report this Week: Is It a Buy, Ahead of Earnings?
16d ago
BioArctic Partners with Novartis for Neurodegeneration Treatment
Premium
Company Announcements
BioArctic Partners with Novartis for Neurodegeneration Treatment
16d ago
BioArctic’s Leqembi Launches in EU, Targeting Alzheimer’s Disease
Premium
Company Announcements
BioArctic’s Leqembi Launches in EU, Targeting Alzheimer’s Disease
17d ago
BioArctic AB to Present Q2 2025 Financial Report
PremiumCompany Announcements
BioArctic AB to Present Q2 2025 Financial Report
21d ago
BioArctic Reports Strong Q2 2025 Leqembi Sales Boost
PremiumCompany Announcements
BioArctic Reports Strong Q2 2025 Leqembi Sales Boost
1M ago
BioArctic’s Lecanemab Shows Promising Long-Term Benefits in Alzheimer’s Treatment
PremiumCompany Announcements
BioArctic’s Lecanemab Shows Promising Long-Term Benefits in Alzheimer’s Treatment
1M ago
BioArctic and Eisai to Present Lecanemab Data at AAIC 2025
PremiumCompany Announcements
BioArctic and Eisai to Present Lecanemab Data at AAIC 2025
2M ago
BioArctic’s Alzheimer’s Drug Lecanemab Wins Prestigious Bioindustry Award
PremiumCompany AnnouncementsBioArctic’s Alzheimer’s Drug Lecanemab Wins Prestigious Bioindustry Award
2M ago
BioArctic Founder Awarded Prestigious Prize for Alzheimer’s Research
Premium
Company Announcements
BioArctic Founder Awarded Prestigious Prize for Alzheimer’s Research
3M ago
BioArctic Advances Exidavnemab Study Following Positive Safety Review
Premium
Company Announcements
BioArctic Advances Exidavnemab Study Following Positive Safety Review
3M ago
BioArctic AB Unveils Strategic Vision for 2030 at Capital Markets Day
PremiumCompany Announcements
BioArctic AB Unveils Strategic Vision for 2030 at Capital Markets Day
3M ago
BioArctic AB Issues New Shares Under Stock Option Program
PremiumCompany Announcements
BioArctic AB Issues New Shares Under Stock Option Program
3M ago
BioArctic AB Annual General Meeting Resolutions and New Incentive Program
PremiumCompany Announcements
BioArctic AB Annual General Meeting Resolutions and New Incentive Program
4M ago
BioArctic Gains EU Orphan Designation for MSA Treatment
PremiumCompany Announcements
BioArctic Gains EU Orphan Designation for MSA Treatment
4M ago
BioArctic’s Q1 2025 Success: Leqembi’s Approval and Strategic Partnerships Boost Financial Performance
PremiumCompany AnnouncementsBioArctic’s Q1 2025 Success: Leqembi’s Approval and Strategic Partnerships Boost Financial Performance
4M ago
BioArctic AB Class B (B9A) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
BioArctic AB Class B (B9A) Q1 Earnings Cheat Sheet
4M ago
Eisai Projects Significant Growth for Alzheimer’s Drug Leqembi
Premium
Company Announcements
Eisai Projects Significant Growth for Alzheimer’s Drug Leqembi
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >